| Optical control of protein activity by fluorescent protein domains XX Zhou, HK Chung, AJ Lam, MZ Lin Science 338 (6108), 810-814, 2012 | 330 | 2012 |
| Engineered ACE2 receptor traps potently neutralize SARS-CoV-2 A Glasgow, J Glasgow, D Limonta, P Solomon, I Lui, Y Zhang, MA Nix, ... Proceedings of the National Academy of Sciences 117 (45), 28046-28055, 2020 | 239 | 2020 |
| Fluorescent indicators for simultaneous reporting of all four cell cycle phases BT Bajar, AJ Lam, RK Badiee, YH Oh, J Chu, XX Zhou, N Kim, BB Kim, ... Nature methods 13 (12), 993-996, 2016 | 195 | 2016 |
| Photoswitchable fluorescent proteins: ten years of colorful chemistry and exciting applications XX Zhou, MZ Lin Current opinion in chemical biology 17 (4), 682-690, 2013 | 185 | 2013 |
| Optical control of cell signaling by single-chain photoswitchable kinases XX Zhou, LZ Fan, P Li, K Shen, MZ Lin Science 355 (6327), 836-842, 2017 | 183 | 2017 |
| Engineering luminescent biosensors for point-of-care SARS-CoV-2 antibody detection SK Elledge, XX Zhou, JR Byrnes, AJ Martinko, I Lui, K Pance, SA Lim, ... Nature biotechnology 39 (8), 928-935, 2021 | 132 | 2021 |
| SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assay MJ Peluso, S Takahashi, J Hakim, JD Kelly, L Torres, NS Iyer, K Turcios, ... Science advances 7 (31), eabh3409, 2021 | 130 | 2021 |
| A Single-Chain Photoswitchable CRISPR-Cas9 Architecture for Light-Inducible Gene Editing and Transcription XX Zhou, X Zou, HK Chung, Y Gao, Y Liu, LS Qi, MZ Lin ACS Chemical Biology, 2017 | 126 | 2017 |
| Bi-paratopic and multivalent VH domains block ACE2 binding and neutralize SARS-CoV-2 CJ Bracken, SA Lim, P Solomon, NJ Rettko, DP Nguyen, BS Zha, ... Nature chemical biology 17 (1), 113-121, 2021 | 88 | 2021 |
| ReScan, a multiplex diagnostic pipeline, pans human sera for SARS-CoV-2 antigens CR Zamecnik, JV Rajan, KA Yamauchi, SA Mann, RP Loudermilk, ... Cell Reports Medicine 1 (7), 2020 | 77 | 2020 |
| Competitive SARS-CoV-2 serology reveals most antibodies targeting the spike receptor-binding domain compete for ACE2 binding JR Byrnes, XX Zhou, I Lui, SK Elledge, JE Glasgow, SA Lim, ... MSphere 5 (5), 10.1128/msphere. 00802-20, 2020 | 57 | 2020 |
| Trimeric SARS-CoV-2 Spike interacts with dimeric ACE2 with limited intra-Spike avidity I Lui*, XX Zhou*, SA Lim*, S Elledge* (*contributed equally), P Solomon, ... bioRxiv, 2020 | 36 | 2020 |
| Investigating neuronal function with optically controllable proteins XX Zhou, M Pan, MZ Lin Frontiers in molecular neuroscience 8, 37, 2015 | 29 | 2015 |
| Bispecific VH/Fab antibodies targeting neutralizing and non-neutralizing Spike epitopes demonstrate enhanced potency against SARS-CoV-2 SA Lim, JA Gramespacher, K Pance, NJ Rettko, P Solomon, J Jin, I Lui, ... MAbs 13 (1), 1893426, 2021 | 26 | 2021 |
| Engineering improved antiphosphotyrosine antibodies based on an immunoconvergent binding motif Y Mou, XX Zhou, K Leung, AJ Martinko, JY Yu, W Chen, JA Wells Journal of the American Chemical Society 140 (48), 16615-16624, 2018 | 22 | 2018 |
| A SARS-CoV-2 serological assay to determine the presence of blocking antibodies that compete for human ACE2 binding JR Byrnes, XX Zhou, I Lui, SK Elledge, JE Glasgow, SA Lim, R Loudermilk, ... MedRxiv, 2020 | 13 | 2020 |
| Targeting phosphotyrosine in native proteins with conditional, bispecific antibody traps XX Zhou, CJ Bracken, K Zhang, J Zhou, Y Mou, L Wang, Y Cheng, ... Journal of the American Chemical Society 142 (41), 17703-17713, 2020 | 7 | 2020 |
| Bi-paratopic and multivalent human VH domains neutralize SARS-CoV-2 by targeting distinct epitopes within the ACE2 binding interface of Spike CJ Bracken, SA Lim, P Solomon, NJ Rettko, DP Nguyen, BS Zha, ... bioRxiv, 2020 | 5 | 2020 |
| Competitive SARS-CoV-2 serology reveals most antibodies targeting the spike receptor-binding domain compete for ACE2 binding. mSphere 2020. 5 (5) JR Byrnes, XX Zhou, I Lui, SK Elledge, JE Glasgow, SA Lim, ... Google Scholar There is no corresponding record for this reference, 0 | 4 | |
| Competitive SARS-CoV-2 serology reveals most antibodies targeting the spike receptor-binding domain compete for ACE2 binding. mSphere 5: e00802-20 JR Byrnes, XX Zhou, I Lui, SK Elledge, JE Glasgow, SA Lim, ... | 3 | 2020 |
